Avelumab recommended for metastatic Merkel cell carcinoma in adults

Apr 21, 2021

Acalabrutinib recommended for chronic lymphocytic leukaemia in adults

Regulatory alerts NICE guidelines

Cancer, Oncology, Haematological malignancies, Oncology Room

Acalabrutinib recommended for chronic lymphocytic leukaemia in adults

OnMedica

Apr 21, 2021

Trastuzumab deruxtecan recommended in NICE draft guidance for use in the CDF for breast cancer after two or more anti-HER2 therapies

Regulatory alerts NICE guidelines

Breast cancer, Oncology Room

Trastuzumab deruxtecan recommended in NICE draft guidance for use in the CDF for breast cancer after two or more anti-HER2 therapies

OnMedica

Apr 20, 2021

#VisualAbstract: Lenvatinib plus pembrolizumab improves overall survival and progression free survival for advanced renal cell carcinoma treatment

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract: Lenvatinib plus pembrolizumab improves overall survival and progression free survival for advanced renal cell carcinoma treatment

2 Minute Medicine

Apr 20, 2021

#VisualAbstract BRAF inhibitor and BRAF inhibitor-based combination therapy were tolerable in treating melanoma for a real-world, Chinese population

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Skin cancer, Oncology Room

#VisualAbstract BRAF inhibitor and BRAF inhibitor-based combination therapy were tolerable in treating melanoma for a real-world, Chinese population

2 Minute Medicine

Apr 16, 2021

#VisualAbstract: Endoscopic surgery improves survival compared to radiotherapy in patients with locally recurrent nasopharyngeal carcinoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Ear, nose and throat conditions, Oncology, Oncology Room

#VisualAbstract: Endoscopic surgery improves survival compared to radiotherapy in patients with locally recurrent nasopharyngeal carcinoma

2 Minute Medicine

Apr 15, 2021

#VisualAbstract: Combined anti-PD-1 and anti-CTLA-4 blockade improves survival among patients with BRAF-mutated melanoma and elevated LDH

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Oncology Room

#VisualAbstract: Combined anti-PD-1 and anti-CTLA-4 blockade improves survival among patients with BRAF-mutated melanoma and elevated LDH

2 Minute Medicine

Apr 14, 2021

Aprepitant regimen is linked to decreased chemotherapy-induced nausea and vomiting in women

Quality Evidence Briefings

Quality Evidence Briefings, Gastrointestinal cancer, Oncology Room

Aprepitant regimen is linked to decreased chemotherapy-induced nausea and vomiting in women

2 Minute Medicine

Apr 13, 2021

Regulatory alerts

Oncology, Haematological malignancies, Oncology Room

SMC accepts acalabrutinib for chronic lymphocytic leukaemia (restricted use)

Acalabrutinib is recommended as monotherapy under two indications.

OnMedica

Apr 12, 2021

Regulatory alerts

Oncology, Haematological malignancies, Oncology Room

SMC accepts treatment for relapsed and refractory multiple myeloma (restricted use)

Isatuximab accepted in combination with pomalidomide and dexamethasone for patients receiving fourth-line therapy.

OnMedica

Apr 12, 2021

Clinicopathological heterogeneity in triple-negative breast cancers associated with variable prognosis and therapeutic outcomes

Quality Evidence Briefings

Quality Evidence Briefings, Cancer, Oncology, Breast cancer, Oncology Room

Clinicopathological heterogeneity in triple-negative breast cancers associated with variable prognosis and therapeutic outcomes

2 Minute Medicine

Apr 12, 2021

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma

2 Minute Medicine

Apr 09, 2021

#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Skin cancer, Oncology Room

#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma

2 Minute Medicine

Apr 07, 2021

Quality Evidence Briefings

Quality Evidence Briefings, Oncology, Thoracic cancer , Oncology Room

Tislelizumab plus chemotherapy vs chemotherapy alone as treatment for advanced squamous NSCLC

2 Minute Medicine

Apr 07, 2021

Celecoxib added to adjuvant chemotherapy does not improve survival or recurrence versus placebo in stage III colon cancer

Quality Evidence Briefings

Quality Evidence Briefings, Oncology, Gastrointestinal cancer, Oncology Room

Celecoxib added to adjuvant chemotherapy does not improve survival or recurrence versus placebo in stage III colon cancer

2 Minute Medicine

Apr 06, 2021

Nivolumab in resected esophageal or gastroesophageal junction cancer improved survival

Quality Evidence Briefings

Quality Evidence Briefings, Oncology, Gastrointestinal cancer, Oncology Room

Nivolumab in resected esophageal or gastroesophageal junction cancer improved survival

2 Minute Medicine

Apr 05, 2021

Patients set to benefit from five-minute breast cancer treatment

Regulatory alerts

Oncology, Breast cancer, Oncology Room

Patients set to benefit from five-minute breast cancer treatment

OnMedica

Apr 04, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: Chlormethine gel shows importance in real-world therapeutics in combination with other therapies for mycosis fungoides cutaneous T-cell lymphoma

2 Minute Medicine

Apr 02, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Head and neck cancer, Oncology Room

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

2 Minute Medicine

Apr 01, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Oncology, Haematological malignancies, Oncology Room

#VisualAbstract: TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

2 Minute Medicine

Apr 01, 2021

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with non-inferior overall survival

Quality Evidence Briefings

Quality Evidence Briefings, Oncology, Gastrointestinal cancer, Oncology Room

Shortened duration of adjuvant chemotherapy in individuals with stage III colon cancer may be associated with non-inferior overall survival

2 Minute Medicine

Apr 01, 2021

Oncology Room

About this room